Impact of policy measures targeting benzodiazepines and Benzodiazepine-related drugs in Lithuania: interrupted time series analysis
From a public health perspective, the policy measures implemented in 2020 and 2021 had only a limited impact on the prescribing patterns of benzodiazepines and BZRDs in Lithuania. They continued to be used long-term, highlighting the persistence of potentially irrational prescribing.
Authors
- Daniala L. Weir (ORCID: https://orcid.org/0000-0001-7044-2443)
- Marie L. De Bruin (ORCID: https://orcid.org/0000-0001-9197-7068)
- Inge M. Zomerdijk
- Yared Santa-Ana-Tellez
- Sharon C.M. Essink
- Helga Gardarsdottir
- Tomas Lasys
- Rolf H.H. Groenwold
- Satu J. Siiskonen
Institutions
- University of Waterloo (CA)
- University of Iceland (IS)
- Utrecht University (NL)
- Leiden University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Pharmo Institute (NL)
- Medicines Evaluation Board (NL)
Publication Details
- Journal
- European Journal of Clinical Pharmacology
- Published
- 2026-02-06
- DOI
- https://doi.org/10.1007/s00228-025-03992-7
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00